1-1 of 1
Authors: Chenghui Huang
Journal Article
EDITOR'S CHOICE
Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial
Rheumatology, Volume 63, Issue 3, March 2024, Pages 698–705, https://doi.org/10.1093/rheumatology/kead265
Published: 03 July 2023
